<DOC>
	<DOCNO>NCT00089310</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure sentinel lymph node mapping may improve ability detect cancer spread lymph node . PURPOSE : This clinical trial study well sentinel lymph node mapping work detect cancer spread lymph nodes patient undergo surgery stage I non-small cell lung cancer .</brief_summary>
	<brief_title>Sentinel Lymph Node Mapping Detecting Cancer That Has Spread Lymph Nodes Patients With Non-Small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine feasibility accuracy intraoperative sentinel lymph node map use technetium Tc 99 sulfur colloid patient stage I non-small cell lung cancer . - Determine percentage patient least 1 positive sentinel lymph node identify use procedure . - Determine percentage patient undergoing procedure find positive sentinel lymph nodes metastasis intrathoracic lymph node . Secondary - Determine percentage patient undergoing procedure whose disease stage upgrade due detection micrometastases sentinel lymph node . - Correlate presence micrometastases sentinel lymph node survival patient undergoing procedure . - Determine percentage patient undergoing procedure `` skip metastasis '' pattern ( NZ ) sentinel lymph node . OUTLINE : This multicenter study . Patients receive intraoperative intratumoral injection technetium Tc 99 sulfur colloid . At least 10 minute later , patient undergo sentinel lymph node map use gamma probe . Patients undergo sentinel lymph node dissection tumor resection . Pathology assay perform use sentinel lymph node tissue , include hematoxylin eosin staining , serial section , immunohistochemistry use AE1/AE3/PCK2b cytokeratin antibody . Patients follow every 6 month 2 year annually thereafter .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>1 . Patients clinical stage I lung cancer surgical resection plan eligible . Histologic confirmation lung cancer require prior registration surgical exploration . Preoperative mediatinoscopy allow required patient indication mediatinoscopy . It prefer mediatinoscopy do different setting ( prior registration ) , procedure may do set lobectomy . 2 . No prior therapy diagnosis . 3 . No prior treatment mediastinal radiation therapy . 4 . Age â‰¥ 18 year age . 5 . ECOG performance status : 02 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>stage I non-small cell lung cancer</keyword>
</DOC>